XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Assets    
Cash and due from banks $ 121,220 $ 134,212
Federal funds sold 653 849
Cash and cash equivalents 121,873 135,061
Investment securities available for sale, at fair value 1,212,090 915,895
Equity securities, at fair value 4,705 4,501
Loans 5,748,819 6,131,079
Allowance for credit losses on loans (85,804) (68,502)
Total loans, net 5,663,015 6,062,577
Loans held for sale 8,001 3,811
Premises and equipment, net 84,672 82,814
Other real estate owned 8,646 9,112
Nonmarketable equity securities 41,170 43,421
Accrued interest receivable 27,099 24,934
Loan servicing rights, at lower of cost or fair value 18,400 20,253
Goodwill 161,904 161,904
Other intangible assets, net 13,052 16,108
Company-owned life insurance 209,193 203,485
Other assets 177,663 182,992
Total assets 7,751,483 7,866,868
Deposits:    
Noninterest-bearing demand deposits 1,050,617 1,145,395
Interest-bearing deposits 5,206,219 5,164,134
Total deposits 6,256,836 6,309,529
Short-term borrowings 13,849 34,865
Federal Home Loan Bank advances and other borrowings 425,000 476,000
Subordinated debt 82,744 93,546
Trust preferred debentures 51,058 50,616
Accrued interest payable and other liabilities 103,737 110,459
Total liabilities 6,933,224 7,075,015
Shareholders’ Equity:    
Preferred stock, $2.00 par value; 4,000,000 shares authorized; 115,000 Series A shares, $1,000 per share liquidation preference, issued and outstanding at September 30, 2024 and December 31, 2023, respectively 110,548 110,548
Common stock, $0.01 par value; 40,000,000 shares authorized; 21,393,905 and 21,551,402 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 214 216
Capital surplus 433,615 435,463
Retained earnings 334,522 322,379
Accumulated other comprehensive loss, net of tax (60,640) (76,753)
Total shareholders’ equity 818,259 791,853
Total liabilities and shareholders’ equity $ 7,751,483 $ 7,866,868